Global Hepatitis B Vaccines Market 2014-2018: Key Vendors are GlaxoSmithKline, Merck and Sanofi Pasteur

Sep 29, 2014, 08:25 ET from Research and Markets

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hepatitis B Vaccines Market 2014-2018" report to their offering.

Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated against virus and hepatocytes infected with viruses. This, in turn, leads to the inflammation of the liver. Extra-hepatic manifestations of hepatitis B include polyarteritis nodosa, Gianotti-Crosti syndrome, transient serum sickness-like syndrome, and membranous glomerulonephritis.

Perinatal transmission of hepatitis B virus is the most common mode of infection spread. Age of a person at the time of infection and infecting dose of virus are important factors that determine the severity of acute or chronic hepatitis B. Most of the patients suffering from acute hepatitis B recover spontaneously without significant consequences. The chronic form of infection, in some cases, can progress up to cirrhosis and liver cancer. Hepatitis B infection can be prevented by immunization with hepatitis B vaccines.

The analysts forecast the Global Hepatitis B Vaccines market to grow at a CAGR of 4.00 percent over the period 2013-2018.

This report covers the present scenario and the growth prospects of the Global Hepatitis B Vaccines market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various vaccines intended for active immunization against different serogroups of hepatitis B virus. In terms of composition, the Global Hepatitis B Vaccines market can be segmented into the following: Mono Vaccines and Combination Vaccines.

The report, the Global Hepatitis B Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Hepatitis B Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

One of the key emerging trends in this market is the increasing focus on combination vaccines. These vaccines confer protection against multiple causative agents and thereby decrease the costs incurred in packaging and administering individual vaccines.

According to the report, recommendation of hepatitis B vaccines while traveling is one of the major drivers in the market. Various government bodies have mandated the immunization of travelers visiting hepatitis B-prone areas with prophylactic vaccines for the prevention of the spread of infection and reduction in the chance of epidemic outbreaks.

Further, the report states that inadequate coverage of the vaccine is one of the major challenges in the market. Lack of awareness is a major factor limiting the uptake of vaccines, resulting in low coverage rates.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Disease Overview

06. Introduction

07. Market Landscape

08. Market Segmentation by Composition

09. Market Segmentation by End-user Age Group

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Late-stage Pipeline Candidates

20. Key Vendor Analysis

21. Other Reports in this Series

Companies Mentioned:

  • GlaxoSmithKline
  • Merck
  • Sanofi Pasteur
  • Dynavax Technologies
  • Janssen Pharmaceuticals
  • LG Life Sciences
  • Kaketsuken
  • Shenzhen Kangtai Biological Product

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets